The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.

The biopharmaceutical industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Members supply 90% of all medicines used by the NHS, and are researching and developing over two thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.